European Adverse Event Database Will Be Publicly Accessible
Executive Summary
The European Medicines Agency is developing an extensive database of all approved products that will include information on ongoing clinical trials and adverse events for each drug
You may also be interested in...
Confidential Clinical Trial Database Could Spur Publication – Ex-PhRMA Exec
Creating a database of clinical trial information that would be accessible to journal editors, but not the public, could help encourage companies to publish certain types of trial information, a former Pharmaceutical Research & Manufacturers of America official said
Drug Safety Debate Will Have Long-Term Effect On New Approvals, Troy Says
The current debate over drug safety will have a visible impact on new drug approvals in up to three years, former FDA Chief Counsel Dan Troy said
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011